RxDoctor Payments Data

Elizabeth Bowman, DO

Family Medicine · Gravois Mills, MONPI 1285120865

Payments from drug & device makers

$1,068in general payments, 2019–2025

Across 53 payments — averaging $20.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$304
  • Alkermes, Inc.$206
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$108
  • AstraZeneca$85
  • Amgen$54
  • Otsuka America Pharmaceutical, Inc.$51
  • plus $262 from 10 others

What the payments were for

  • Food & beverage$1,05399%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,068 in reported general payments places this provider in the 65th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$2,788
Medicare patients
54
Services billed
305

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate26$30,464
OzempicSemaglutide25$23,707
EliquisApixaban21$17,271
TrulicityDulaglutide13$16,128
RybelsusSemaglutide13$16,056
Spiriva RespimatTiotropium Bromide16$15,117
JanuviaSitagliptin Phosphate24$13,857
MounjaroTirzepatide12$10,935
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$10,311
MovantikNaloxegol Oxalate15$7,907
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen182$6,294
SymbicortBudesonide/Formoterol Fumarate16$4,853
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen172$4,771
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$3,835
Albuterol Sulfate HfaAlbuterol Sulfate162$3,034

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$16$39,76338 claims
Lilly USA, LLCTrulicity, Mounjaro$19$27,06325 claims
AstraZenecaBreztri Aerosphere, Symbicort$85$15,16432 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Gravois Mills

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →